Non-small-cell相关论文
Complete pathological response in locally advanced non-small-cell lung cancer patient: A case report
BACKGROUND Chemotherapy and radiotherapy followed by durvalumab is currently the standard treatment for locally advanced......
Objective:Epidermal growth factor receptor (EGFR) mutations are strong determinants of tumor response to EGFR tyrosine k......
Molecular Mechanisms Contributing to Resistance to Tyrosine Kinase-Targeted Therapy for Non-Small Ce
One of the most important pathways in non-small cell lung cancer(NSCLC) is the epidermal growth factor receptor(EGFR) pa......
【目的】探讨siRNA干扰肺特异性X蛋白（LUNX）对非小细胞肺癌（NSCLC）细胞系A549增殖和侵袭的影响。【方法】采用脂质体LipofectamineTM 2......
【目的】分析全身伽玛刀联合大剂量维生素C和K3治疗非小细胞肺癌（NSCLC ）的疗效及并发症。【方法】2008年1月1日至2011年4月20日本科......
目的 观察肿瘤相关巨噬细胞(TAMs)U937和非小细胞肺癌细胞(NSCLC)A549在体外不同的共培养条件下,对单核细胞趋化蛋白-1(MCP-1)、巨......
目的 探讨在非小细胞肺癌( NSCLC)标本中棘皮动物微管相关蛋白样4与间变淋巴瘤激酶融合基因(EML4-ALK)变异的复杂性,分析其酪氨酸......
【目的】观察比较奈达铂联合多西他赛化疗方案与顺铂联合多西他赛化疗方案治疗晚期非小细胞肺癌（NSCLC ）的近期疗效及不良反应。【方......
Molecular Mechanisms Contributing to Resistance to Tyrosine Kinase-Targeted Therapy for Non-Small Ce
TOne of the most important pathways in non-small cell lung cancer (NSCLC) is the epidermal growth factor receptor (EGFR)......
Objective:Epidermal growth factor receptor (EGFR) mutations are strong determinants of tumor response to EGFR tyrosine k......
[摘要]目的探討叶酸受体阳性循环肿瘤细胞（FR+-CTCs）联合肿瘤标志物外周血癌胚抗原（CEA）、细胞角蛋白19片段（CYFRA21-1）检测在非小细胞肺......
Clinical observation of platinum-based combined with concurrent three-dimensional conformal radiothe
...
目的研究拓扑替康(TPT)、顺铂(DDP)联合化疗治疗晚期非小细胞肺癌(NSCLC)的近期疗效及毒副反应.方法TPT0.75mg/m2,静脉滴注,第1～5d;......
目的探讨杂交式单操作孔胸腔镜肺叶切除术治疗早期肺癌的临床效果。方法将170例早期非小细胞肺癌手术患者分为杂交式单操作孑L胸腔......
Objective: To investigate the expression of p120ctn in non-small-cell lungcancer (NSCLC) and its relationship with clini......
目的探讨非小细胞肺癌（NSCLC）中RhoB和E一钙黏蛋白（E—cadherin）的表达及其临床意义。方法采用免疫组化SuperPicTureTMPolymerZ．步法，检......
目的检测凋亡调节蛋白抑癌基因p53和Bcl-2家族在非小细胞肺癌(NSCLC)标本中的相关性和预后意义.方法采用免疫组化法用特异性针对人......
目的探讨鸦胆子油乳剂对老年非小细胞肺癌（NSCLC）患者外周血T细胞亚群及生活质量的影响。方法选择我院收治的78例老年NSCLC患者为研......
目的评价10-羟基喜树碱(拓僖,HCPT)联合异环磷酰胺(IFO)化疗方案治疗进展期铂类耐药非小细胞肺癌(NSCLC)的有效性及安全性.方法经......
目的：观察重组人血管内皮抑制素恩度治疗复治的晚期非小细胞肺癌的疗效和安全性。方法：2006年7月至2008年3月本院31例经病理证实的符......
目的探讨老年人肺结核并发非小细胞肺癌的诊断，以及外科治疗方法和患者预后。方法搜集首都医科大学附属北京胸科医院2002年1月至201......
背景与目的SEREX（Serological analysis of recombinant expression libraries）是近年来发展起来的一种寻找肿瘤相关抗原的方法，通过......
目的研究恶性肿瘤患者外周血细胞对化疗药物的敏感性,为临床筛选化疗方案、实行肿瘤个体化疗提供依据。方法应用MTT法体外测定160......
目的:动态观察围手术期非小细胞肺癌(NSCLC)患者外周循环癌细胞(circulating tumor cells,CTCs)的存在状况,评价手术操作促进癌细......
Clinical Observation on Treatment of Non-Parvicellular Carcinoma of the Lung with Jin Fu Kang Oral L
Jin Fu 坑口头的液体([标志：看见文本]) 用为补充 qi 和有营养的 yin 的繁体中文药做的，与 qi 和 yin 的缺乏在肺癌根据普通症状被开......
Therapeutic Effects of Kanglaite Injection Combined with Chemotherapy on Advanced Non-small-cell Lun
The objective of this study was to study the therapeutic effect of Kanglaite injection combined with chemotherapy in the......
目的 探讨循环肿瘤细胞（CTC）、外周血代替肿瘤组织进行X线修复交错互补基因（XRCC1）多态性检测的可行性。 方法 选取初治的非小细胞肺癌......
目的 探讨非小细胞肺癌（NSCLC）根治手术的患者切除修复交叉互补基因1（ERCC1）的表达对预后的影响。 方法 收集137例接受肺叶切除+系统性......
Non-small-cell lung cancer remains a leading cause of death around the world.For most cases,the only chance of cure come......
目的：探讨基质金属蛋白酶-9（MMP-9）和组织金属蛋白酶抑制剂-1（TIMP-1）的表达与非小细胞肺癌（NSCLC）临床病理学特征之间的关系.方法：采用免......
Involvement of miR-214 and miR-375 in Malignant Features of Non-Small-Cell Lung Cancer by Down-Regul
A tumor suppressor gene, CADM1, encoding an immunoglobulin superfamily cell adhesion molecule, is inactivated in various......
Development of Aseptic Renal Abscess in a Patient with Non-Small-Cell Lung Cancer with ALK Transloca
Background: Crizotinib is a tyrosine kinase inhibitor of ALK, MET and ROS1. In a safety database trial, it was suggested......
目的：研究他汀类药物能否协同增强组蛋白去乙酰化酶抑制剂辛二酰苯胺异羟肟酸（SAHA）对非小细胞肺癌A549细胞的生长抑制和凋亡诱导作用......
目的探讨癌组织p53、c-erbB2、MRP蛋白表达与非小细胞肺癌（NSCLC）临床病理特征的关系及其预后评估意义。方法应用免疫组织化学方法检......
客观表皮的生长因素受体(EGFR ) 变化是对在 non-small-cell 肺癌症(NSCLC ) 的 EGFR 酷氨酸 kinase 禁止者的肿瘤反应的强壮的决......
Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Ch
Objective: Crizotinib has demonstrated promising efficacy in patients with anaplastic lymphoma kinase(ALK)-positive non-......
Sequential therapy according to distinct disease progression patterns in advanced ALK-positive non-s
Objective: Crizotinib is recommended as the first-line therapy for advanced anaplastic lymphoma kinase(ALK)-positive non......
The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung ca
Immune checkpoint inhibitors(ICIs)are new and promising therapeutic agents for non-small cell lung cancer(NSCLC).However......
Background Lung cancer is the most common cancer worldwide and remains the leading cause of cancer-related mortality.A m......
Objective: Advances in diagnostic imaging techniques, such as 18F-fluorodeoxyglucose positron emission tomography (FDG-P......
Biomarker Testing Rates in Patients with Advanced Non-Small Cell Lung Cancer Treated in the Communit
Introduction: Over the past few years, molecular targeted therapies have been?emerging for the treatment of metastatic n......
【目的】探讨国产多西紫杉醇（多帕菲,齐鲁制药）单用以及多帕菲＋顺铂联合化疗方案对非小细胞肺的临床疗效和安全性,并以进口多西紫杉醇......
Pretreatment levels of circulating endothelial cells on efficacy of first-line therapy in patients w
Background:Elevated levels of circulating endothelial cells might reflect significant vascular damage and dysfunction.Re......
